Craig Lipset has been at the forefront of innovation in clinical trials and medicine development. For over 20 years Lipset has been leading the transformation of clinical trials, pioneering new approaches to bring research closer to patients and accelerate new cures with leading-edge technology. Audiences come away both energized and informed – excited by the potential for accelerating medical breakthroughs while aware of what it will take for us to get there.
Lipset currently serves as Co-Chair of the Decentralized Trials & Research Alliance (DTRA), a new non-profit collaboration he launched in 2020. DTRA is the world’s leading initiative to ease the burden of research participation, advancing the adoption of new technologies and approaches to enable patients to engage in research in more flexible and accessible ways. DTRA members include 85 organizations including regulatory agencies, pharmaceutical and healthcare companies, technology and service providers, research sites and advocacy groups. This has become a remarkable group with membership spanning FDA, Pfizer, United HealthCare, CVS, Amazon, IQVIA, StandUp2Cancer and beyond.
For nearly a decade he was the Head of Clinical Innovation at Pfizer, leading digital initiatives, patient engagement and collaborations across all therapeutic areas around the globe. During that tenure he launched multiple “industry firsts” — from the first fully remote/virtual clinical trial for a new medicine to the first returning of results and data to research participants.
Lipset brings 360 degrees of perspective to the future of medicine development – as an industry insider, a trial innovator, a technologist, and as a patient advocate. He blends these experiences to bring audiences on a journey spanning patient empowerment, digital development, remote/in-home clinical trials and the future of data ownership. He reveals who will be disrupted and displaced along the way to these various futures.
The digital future is humanized with Lipset’s personal experience as a patient with a rare pulmonary disease, and how his own journey as a patient has defined and informed his vision for the future. He is the Managing Partner of Clinical Innovation Partners, a growth advisory with clients spanning technology and biopharmaceutical companies, leading universities, and the venture community, and has been listed among the PharmaVOICE most inspiring people in the life sciences (Red Jacket hall-of-fame), Pharmaceutical Executive’s Emerging Leaders, CenterWatch Top 20 Innovators in Clinical Trials, and the AlleyWatch Who’s Who in eHealth.